Hepatitis Drugs Markets in China, 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Hepatitis Drugs Markets in China" report has been added to ResearchAndMarkets.com's offering.

China's demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.

This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented. Major producers in China are profiled.

Key Topics Covered:

I. INTRODUCTION

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators

Industrial Output

Population and Labor

Foreign Investment

Foreign Trade

Financial and Tax Regulations

Banking System and Regulations

Foreign Exchange

Taxes, Tariff and Custom Duties

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

Hepatitis Drugs Industry Structure

Market Size

Market Growth Drivers

Hepatitis Drugs Industry Sales Volumes

Major Producer Facility Locations and Sales Volumes

Market Share of Key Producers

Labor Cost

Potential Entrants

Major Distributors

Major Foreign Investment

Technology Development

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

Overview

Sales Volumes of Hepatitis Drugs by Region

Hepatitis Drugs Sales Volumes

Liver Protection Drugs

Nucleoside Drugs

Interferon (IFN)

Other Hepatitis Drugs

Hepatitis Drugs Imports and Exports

Hepatitis Drugs Imports

Hepatitis Drugs Exports

Pricing Trend

V. HEPATITIS DRUGS MARKET OUTLOOK

Hepatitis Drugs Market Outlook Overview

Government Regulation

Health Care Insurance Industry Overview

Consumer Spending Trends

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview

China's Distribution System

Hepatitis Drugs Distribution Channels

Transportation and Freight Infrastructure

Communications

China's Market Entry

Licensing

Franchising

E-commerce

Trading Companies and Local Agents

Representative Offices and Chinese Subsidiaries

Wholly Foreign Owned Enterprises

VII. HEPATITIS DRUGS PRODUCER DIRECTORY

Companies Mentioned

  • Shenzhen Kexing Biotech Co., Ltd.
  • The United Laboratories (Zhuhai) Pharmaceutical Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/htgr8v/hepatitis_drugs?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs, Liver and Kidney Disorders Drugs